Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
321
datasets available to search
ShareScore release 0.9.0
Dataset results
321 results for “AKT”
Increased ONECUT2 induced by Helicobacter pylori promotes gastric cancer cell stemness via AKT-related pathway
GEO Series GSE267263. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer
GEO Series GSE136131. Homo sapiens. 8 samples. Type: Expression profiling by array.
Loss of G-Protein Pathway Suppressor 2 promotes tumor growth through activation of AKT signaling
GEO Series GSE161283. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing.
Human AsPC1-CFP and AsPC1-AKT PDAC orthotopic tumors: Lean vs Obese
GEO Series GSE99289. Homo sapiens. 36 samples. Type: Expression profiling by array.
ELOVL2 is a novel tumor suppressor attenuating tamoxifen resistance in breast cancer via suppressing the AKT pathway [methylation 850K]
GEO Series GSE132616. Homo sapiens. 2 samples. Type: Methylation profiling by array.
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of diffuse large B-cell lymphoma
GEO Series GSE92619. Homo sapiens. 40 samples. Type: Expression profiling by array.
A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-overexpressing solid tumor malignancies
GEO Series GSE75087. Homo sapiens. 27 samples. Type: Expression profiling by array.
CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy
GEO Series GSE166767. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
Akt regulates Progesterone Receptor B transcription
GEO Series GSE72708. Homo sapiens. 12 samples. Type: Expression profiling by array.
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed B
ClinicalTrials.gov study NCT01705340. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AKT Inhibitor in Oestrogen Positive Breast Cancer
ClinicalTrials.gov study NCT02077569. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunotherapy, Hormone Therapy, and AKT Inhibitor for Premenopausal ER Positive MBC
ClinicalTrials.gov study NCT05720260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer
ClinicalTrials.gov study NCT02929797. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients
ClinicalTrials.gov study NCT01915576. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Canc
ClinicalTrials.gov study NCT05593497. IPD Sharing: NO. Countries: 1. Publications: 0.
Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT01281163. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
ClinicalTrials.gov study NCT03580239. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
ClinicalTrials.gov study NCT05538897. IPD Sharing: YES. Countries: 1. Publications: 0.
Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT)
ClinicalTrials.gov study NCT05459337. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-label Study to Investigate the Safety, Tolerability, PK, and Pharmacodynamics of the AKT Inhibitor GSK690693
ClinicalTrials.gov study NCT00493818. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.